0000899243-22-026194.txt : 20220715
0000899243-22-026194.hdr.sgml : 20220715
20220715205450
ACCESSION NUMBER: 0000899243-22-026194
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220713
FILED AS OF DATE: 20220715
DATE AS OF CHANGE: 20220715
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mazur Marc
CENTRAL INDEX KEY: 0001361226
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38914
FILM NUMBER: 221087982
MAIL ADDRESS:
STREET 1: 31 WEST 52ND ST. 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celularity Inc
CENTRAL INDEX KEY: 0001752828
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831702591
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 170 PARK AVE
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
BUSINESS PHONE: (908) 768-2170
MAIL ADDRESS:
STREET 1: 170 PARK AVE
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
FORMER COMPANY:
FORMER CONFORMED NAME: GX Acquisition Corp.
DATE OF NAME CHANGE: 20180912
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-07-13
0
0001752828
Celularity Inc
CELU
0001361226
Mazur Marc
C/O CELULARITY INC.
170 PARK AVENUE
FLORHAM PARK
NJ
07932
1
0
0
0
Class A Common Stock
2022-07-13
4
A
0
36145
0.00
A
36145
D
Stock Option (Right to Buy)
4.15
2022-07-13
4
A
0
54152
0.00
A
2032-07-13
Class A Common Stock
54152
54152
D
These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs is shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, July 13, 2022, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
This option is granted under the Issuer's 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, July 13, 2022, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
/s/ Keary Dunn, Attorney-in-Fact
2022-07-15